Jeet Mahal

Jeet Mahal is a seasoned executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as a Board Member at Celito Tech, Inc., since January 2024, and as Chief Operating Officer at Jasper Therapeutics since December 2019, Jeet Mahal has held various leadership positions, including Chief Operating and Financial Officer and Chief Financial and Business Officer at Jasper Therapeutics. Prior experience includes notable roles at Portola Pharmaceuticals, where Jeet Mahal was Vice President of Strategic Marketing and Vice President of Business Development, overseeing significant collaborations and corporate financings. Previous positions at Johnson & Johnson, Navigant Consulting, LumiCyte Inc., Redleaf Group, and Cor Therapeutics further underscore a robust career focused on business development, product commercialization, and drug development. Jeet Mahal holds multiple advanced degrees, including an MBA from Duke University and a Master's in Molecular and Cell Biology from the Illinois Institute of Technology.